By rray, 26 January, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text If reduced LV function trial of rhythm control recommended to evaluate if AF is contributing to reduced LV function If HFrEF routine pharm rhythm control no benefit vs rate control If HFrEF consider catheter ablation to improve sx QOL and CV outcomes and reduce mortality and HF hospitalizations If HFpEF ablation also an option Patient Type Detail Header (Long) Considerations for rhythm vs. rate control: